OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
Cathrine Scheepers, Valerie Bekker, Colin Anthony, et al.
Cell Reports (2020) Vol. 33, Iss. 8, pp. 108430-108430
Open Access | Times Cited: 24
Cathrine Scheepers, Valerie Bekker, Colin Anthony, et al.
Cell Reports (2020) Vol. 33, Iss. 8, pp. 108430-108430
Open Access | Times Cited: 24
Showing 24 citing articles:
Antiviral neutralizing antibodies: from in vitro to in vivo activity
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
Valérie Lorin, I. Fernández, Guillemette Masse‐Ranson, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 3
Open Access | Times Cited: 22
Valérie Lorin, I. Fernández, Guillemette Masse‐Ranson, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 3
Open Access | Times Cited: 22
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 4
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 4
Targeting Fc effector function in vaccine design
Simone I. Richardson, Penny L. Moore
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 467-477
Closed Access | Times Cited: 21
Simone I. Richardson, Penny L. Moore
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 467-477
Closed Access | Times Cited: 21
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
Simone I. Richardson, Frances Ayres, Nelia P. Manamela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Simone I. Richardson, Frances Ayres, Nelia P. Manamela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus
Fengjuan Li, Sheng-Ze Wu, Lv Lv, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012623-e1012623
Open Access | Times Cited: 2
Fengjuan Li, Sheng-Ze Wu, Lv Lv, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012623-e1012623
Open Access | Times Cited: 2
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
Thandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Thandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
Jay Lubow, Lisa M. Levoir, Duncan Ralph, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011722-e1011722
Open Access | Times Cited: 5
Jay Lubow, Lisa M. Levoir, Duncan Ralph, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011722-e1011722
Open Access | Times Cited: 5
Antibody class-switching as a strategy to improve HIV-1 neutralization
Cathrine Scheepers, Simone I. Richardson, Thandeka Moyo-Gwete, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 11, pp. 979-988
Open Access | Times Cited: 9
Cathrine Scheepers, Simone I. Richardson, Thandeka Moyo-Gwete, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 11, pp. 979-988
Open Access | Times Cited: 9
Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice
Reem Alatrash, Varun Vaidya, Bobby Brooke Herrera
Journal of Virology (2024)
Open Access | Times Cited: 1
Reem Alatrash, Varun Vaidya, Bobby Brooke Herrera
Journal of Virology (2024)
Open Access | Times Cited: 1
Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
Jay Lubow, Lisa M. Levoir, Duncan Ralph, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Jay Lubow, Lisa M. Levoir, Duncan Ralph, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
HIV-1 Entry and Prospects for Protecting against Infection
J. Bruxelle, Nino Trattnig, Marianne Mureithi, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 228-228
Open Access | Times Cited: 11
J. Bruxelle, Nino Trattnig, Marianne Mureithi, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 228-228
Open Access | Times Cited: 11
Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
Blandine Noailly, Melyssa Yaugel-Novoa, Justine Werquin, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 903-903
Open Access | Times Cited: 5
Blandine Noailly, Melyssa Yaugel-Novoa, Justine Werquin, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 903-903
Open Access | Times Cited: 5
Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice
Reem Alatrash, Varun Vaidya, Bobby Brooke Herrera
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Reem Alatrash, Varun Vaidya, Bobby Brooke Herrera
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dynamic Modeling of Antibody Repertoire Reshaping in Response to Viral Infections
Zhaobin Xu, Junxiao Xu, Hongmei Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zhaobin Xu, Junxiao Xu, Hongmei Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cells
Eirini Moysi, Ashish Sharma, Sijy O’Dell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Eirini Moysi, Ashish Sharma, Sijy O’Dell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dynamic modeling of antibody repertoire reshaping in response to viral infections
Zhaobin Xu, Qingzhi Peng, Junxiao Xu, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109475-109475
Closed Access
Zhaobin Xu, Qingzhi Peng, Junxiao Xu, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109475-109475
Closed Access
Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP
Justin C. Smith, Prabhu S. Arunachalam, Traci Legere, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1386-1386
Open Access
Justin C. Smith, Prabhu S. Arunachalam, Traci Legere, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1386-1386
Open Access
Bacterial coloration immunofluorescence strip for ultrasensitive rapid detection of bacterial antibodies and targeted antibody-secreting hybridomas
Shuiqin Fang, Hao Yang, Cheng Liu, et al.
Journal of Immunological Methods (2021) Vol. 501, pp. 113208-113208
Closed Access | Times Cited: 4
Shuiqin Fang, Hao Yang, Cheng Liu, et al.
Journal of Immunological Methods (2021) Vol. 501, pp. 113208-113208
Closed Access | Times Cited: 4
Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility
Kemin Tan, Junjian Chen, Yu Kaku, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Kemin Tan, Junjian Chen, Yu Kaku, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
Thandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Thandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
Cathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010450-e1010450
Open Access | Times Cited: 1
Cathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010450-e1010450
Open Access | Times Cited: 1
Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility
Kemin Tan, Junjian Chen, Yu Kaku, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access
Kemin Tan, Junjian Chen, Yu Kaku, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
Cathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Cathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
